Suppr超能文献

移植后早期人类白细胞抗原定义的微嵌合体并不预示稳定的肺移植物功能。

Human leucocyte antigen-defined microchimerism early post-transplant does not predict for stable lung allograft function.

机构信息

Department of Medicine, Monash University, Central Clinical School, Melbourne, Vic., Australia.

出版信息

Clin Exp Immunol. 2013 Jun;172(3):483-9. doi: 10.1111/cei.12075.

Abstract

Microchimerism is the presence of foreign cells in an individual below 1% of total cells, which can occur in the setting of solid organ transplantation. This study quantitated donor-derived cellular subsets longitudinally in human leucocyte antigen (HLA)-mismatched lung transplant recipients (LTR) during the first post-operative year and evaluated the pattern of peripheral microchimerism with clinical outcomes. Peripheral blood mononuclear cells (PBMC) isolated from non-HLA-B44 LTR who received HLA-B44 allografts were sorted flow cytometrically into three cellular subsets. Real-time quantitative polymerase chain reaction (q-PCR) demonstrated that donor-derived HLA-B44 microchimerism is a common phenomenon, observed in 61% of patients. The level of donor-derived cells varied across time and between LTR with frequencies of 38% in the B cells/monocytes subset, 56% in the T/NK cells subset and 11% in the dendritic cells (DC) subset. Observations highlighted that microchimerism was not necessarily associated with favourable clinical outcomes in the first year post-lung transplantation.

摘要

微嵌合体是指个体中存在低于总细胞数 1%的外来细胞,这种情况可能发生在实体器官移植中。本研究在 HLA 错配肺移植受者(LTR)术后第一年,对供体来源的细胞亚群进行了纵向定量,并评估了外周微嵌合体与临床结局的关系。从接受 HLA-B44 同种异体移植物的非 HLA-B44 LTR 中分离外周血单个核细胞(PBMC),并通过流式细胞术将其分为三个细胞亚群。实时定量聚合酶链反应(q-PCR)显示,供体 HLA-B44 微嵌合体是一种常见现象,在 61%的患者中观察到。供体衍生细胞的水平随时间和 LTR 而变化,B 细胞/单核细胞亚群的频率为 38%,T/NK 细胞亚群的频率为 56%,树突状细胞(DC)亚群的频率为 11%。研究结果表明,微嵌合体并不一定与肺移植后第一年的良好临床结局相关。

相似文献

2
Differential dynamics of donor DC and non-DC peripheral blood mononuclear cell microchimerism in lung transplantation.
Clin Immunol. 2009 Nov;133(2):179-83. doi: 10.1016/j.clim.2009.07.012. Epub 2009 Aug 19.
3
Chimerism of dendritic cell subsets in peripheral blood after lung transplantation.
J Heart Lung Transplant. 2011 Jun;30(6):691-7. doi: 10.1016/j.healun.2011.01.706. Epub 2011 Mar 9.
7
Donor cell microchimerism in kidney transplantation: Implications for graft function.
Int J Immunogenet. 2020 Dec;47(6):494-500. doi: 10.1111/iji.12492. Epub 2020 Sep 2.

本文引用的文献

3
5
Is durable macrochimerism key to achieving clinical transplantation tolerance?
Curr Opin Organ Transplant. 2011 Aug;16(4):343-4. doi: 10.1097/MOT.0b013e328348e67a.
6
Microchimerism in promoting graft acceptance in clinical transplantation.
Curr Opin Organ Transplant. 2011 Aug;16(4):345-52. doi: 10.1097/MOT.0b013e3283489a42.
7
Chimerism of dendritic cell subsets in peripheral blood after lung transplantation.
J Heart Lung Transplant. 2011 Jun;30(6):691-7. doi: 10.1016/j.healun.2011.01.706. Epub 2011 Mar 9.
8
Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.
Gastroenterology. 2011 Jan;140(1):51-64. doi: 10.1053/j.gastro.2010.10.059. Epub 2010 Nov 9.
9
Differential dynamics of donor DC and non-DC peripheral blood mononuclear cell microchimerism in lung transplantation.
Clin Immunol. 2009 Nov;133(2):179-83. doi: 10.1016/j.clim.2009.07.012. Epub 2009 Aug 19.
10
Tolerance and chimerism after renal and hematopoietic-cell transplantation.
N Engl J Med. 2008 Jan 24;358(4):362-8. doi: 10.1056/NEJMoa074191.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验